← Leaderboards
Daniel Patrick Hollern
Michigan State University
$204,402
Attributed
$204,402
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $59.2K · FY2014–18$100K$75K$50K$25K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$204,402 · 2
By mechanism
F32$170,802 · 1
F31$33,600 · 1
Top collaborators
No co-investigators on record.
Most similar at Michigan State University
Same institution · by research overlap
- Eran Robert Andrechek$3,594,588
- Yue Cao$10,548,992
- Melissa Millerick-May$3,711,302
- Sandra Z Haslam$11,157,280
- Jonathan Rennhack$609,248
Others in their field
Top investigators on “Training”
- Jeffrey P Krischer · University Of South Florida$314,856,919
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Daniel R Kuritzkes · Brigham And Women'S Hospital$258,658,543
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$239,830,683
- Steven E Reis · University Of Pittsburgh At Pittsburgh$232,330,444
Research focus
TrainingGene Expression ProfilingMelanomaUnited States National Institutes Of HealthMalignant NeoplasmsBioinformaticsHuman DiseaseMammary NeoplasmsMouse ModelBaseMolecularMissionMalignant Breast NeoplasmBiomarker SelectionCancer PatientCtla4 GeneBreast Cancer TherapyColorectal CancerBiomarker IdentificationDna Copy NumberCohortClinical TrialsBiological MarkersChemotherapy
Grant awards (5)
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer$59,038
F32 · FY2018 · CA · contact PI
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer$56,694
F32 · FY2017 · CA · contact PI
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer$2,528
F32 · FY2017 · CA · contact PI
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer$52,542
F32 · FY2016 · CA · contact PI
Illuminating the E2F Transcription Factors Control of Breast Cancer Metastasis$33,600
F31 · FY2014 · CA · contact PI